Chargement en cours...
Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses.
Xylazine (XYL) administration in horses is accompanied by significant cardiovascular depression characterized by a 25-35% decrease in cardiac output (CO) which is likely to compromise tissue oxygen delivery (DO2), and usually vagally mediated bradycardia is an important cause of this reduced cardiov...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1997
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1189385/ https://ncbi.nlm.nih.gov/pubmed/9114960 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|